UCSF Seeks to Increase Diversity Access to Clinical Trials Via IMPACT Study

May 13, 2019 | Cancer, Clinical Trials, Diversity, Diversity in Clinical Trials, Oncology

University of California, San Francisco (UCSF) is launching an effort to make clinical trials more accessible reports television station Fox KTVU 2.

Presently, UCSF leads a study that aims to make clinical trials more accessible to various underserved communities from low income patients to communities of color. Known as “IMPACT” it represents a collaborative partnership with USC and the Danville-based nonprofit “Lazarex Cancer Foundation.” Guests on the recent television show include Dr. Kim Rhoads, Director of the UCSF Office of Community Engagement and Dana Dornsife, Founder of Lazarex Cancer Foundation. IMPACT stands for Improving Patient Access to Cancer Clinical Trials. See the link for more on IMPACT. Follow the link below to watch the coverage.


Pin It on Pinterest